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Combined glomerular deposition of polymeric rat IgA and IgG at least in part, polymeric [5] and can be simultaneously
aggravates renal inflammation. accompanied by complement component depositions,
Background. IgA nephropathy (IgAN) is characterized by such as C3 [6] and C5b-9 [7].deposition in the glomerular mesangium of IgA together with
IgA is the sole immunoglobulin detected in at leastC3, C5b-9, and properdin. IgG deposition as a risk factor in
25% of the patients with IgAN. IgG and/or IgM accom-IgAN was recently confirmed by a long-term follow-up of pa-
tients with IgAN. We previously reported on an acute model pany depositions of IgA in 60 to 83% and 22 to 66% of
of IgA-mediated glomerular inflammation in Wistar rats. the renal biopsies, respectively [8]. Mesangial deposition
Methods. To investigate the effect of the combination of of IgG in kidneys of patients in IgAN was recently shownIgA and IgG on glomerular injury, Wistar rats were injected
to be an independent determinant of disease progressionwith a minimum dose of rat IgG in the presence or absence
[1]. These mesangial codeposits may participate in theof a subnephritogenic dose of polymeric rat IgA. Subsequently,
glomerular complement activation, influx of inflammatory cells, nephritogenesis in the majority (85%) of patients with
proteinuria, and hematuria were assessed. symptomatic IgAN and may cause a less favorable prog-
Results. Administration of IgG to the rats resulted in maxi- nosis when compared with patients with exclusive IgAmal proteinuria of 20.3 6 12.1 mg/24 h on day 2 and an absence
deposits [1, 6, 9–11]. However, whether the presence ofof overt glomerular inflammation. Administration of polymeric
IgG in the mesangial area is a risk factor is still controver-rat IgA antibodies to rats resulted in hematuria with a moderate
mesangial complement deposition. In the combination group, sial. Established indicators of poor prognosis or clinical
however, glomerular deposition of C5b-9 was dramatically in- outcome are glomerular or interstitial scleroses, IgA de-
creased. This was accompanied by increased proteinuria as posits in the peripheral capillary wall, and proteinuriacompared with rats receiving IgA or IgG antibody injections
[reviewed in 5].alone on day 7. Microhematuria occurred in rats receiving
either polymeric rat IgA or IgG alone or the combination. Animal models for IgAN demonstrate the pathogenic
While both rat IgG and polymeric IgA induced minor mesan- effect of IgA on the glomerular mesangial area [12–14].
gial cell (MC) proliferation and MC lysis, the combination These include models using oral or systemic immuniza-
resulted in a pronounced, significant increased percentage of
tion, infusion of preformed immune complexes, systemicaneurysm formation on day 7 after injection.
viral infection, hepatobiliary dysfunction, or spontaneousConclusions. We conclude that in this model of IgA-induced
glomerulopathy, a selective, complement-dependent glomeru- occurrence of IgAN [reviewed in 15]. The exact quantity
lar inflammation is induced in Wistar rats by glomerular code- of deposited IgA could not be adequately controlled in
position of rat isotypic monoclonal antibodies. these studies, as reflected by variable immunohistochem-
ical properties of the affected kidneys. Hematuria and
mesangial cell (MC) proliferation were detected, provided
Primary IgA nephropathy (IgAN) is the most preva- the glomerular presence of other immunoglobulin iso-
lent, immunologically mediated form of glomerulone- types [16, 17], so that the relative contribution of IgA-IC
phritis (GN). Glomerular mesangial IgA deposits charac- or polymeric IgA alone in IgAN disease pathogenesis
terize renal disease in humans [1–4]. Deposited IgA is, cannot be made.
Recently, we reported on the aggravating effect of
mouse IgG2a anti–Thy-1.1 antibodies on IgA anti-Thy-1.1–Key words: complement C3 and C5b-9, progressive renal disease, glo-
merulonephritis, mesangium, animal model of IgAN, kidney injury. induced glomerulopathy in rats [18]. In this heterologous
model, mouse IgG and mouse IgA cooperatively activateReceived for publication September 22, 1999
the rat complement cascade.and in revised form December 28, 1999
Accepted for publication January 18, 2000 To study the homologous situation (rat antibodies in
the rat), we used rat IgA monoclonal antibodies with aÓ 2000 by the International Society of Nephrology
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specificity for 2,4-dinitrophenol (DNP) in combination (Eastman, Rochester, NY, USA), Dowex AG1-X8
with rat IgG directed against the same hapten. This re- (Serva, Heidelberg, Germany), protein A-Sepharose 4B,
producible, reliable experimental model resembles fea- HiLoad 26/60 Superdex 200 prep grade (Pharmacia LKB
tures of IgAN. Using rat monoclonal antibodies with Biotechnology, Uppsala, Sweden), and pepsin (Worting-
specificity for DNP, we previously showed that polymeric ton; Biochem Corp., Freehold, NJ, USA) were purchased
IgA, but not monomeric IgA, induces complement- as indicated.
dependent GN in rats [2]. Quantitated amounts of poly-
meric rat IgA or monoclonal IgG carrying identical anti- Rats
gen specificity but different class-determined activities Studies were performed in young male Wistar rats
can be specifically targeted to the mesangium without weighing approximately 150 g. Rats were housed in ac-
any interference of mucosal compartments. This model credited animal facilities. They were fed pelleted food
can be readily used to determine the inflammatory effect and had access to water ad libitum. Experiments were
of IgG on polymeric IgA-induced glomerulopathy. In performed in accord with the National Institutes of Health
the present study, we report that combining rat IgG Guide for the Care and Use of Laboratory Animals.
together with polymeric rat IgA induces a pronounced
GN in rats with prolonged proteinuria and glomerular Generation and production of rat IgG and polymeric
C5b-9 deposition. rat IgA anti-DNP antibodies
Experiments were performed with IgA produced by
METHODS the hybridoma cell line LO-DNP-45. This cell line pro-
duces monomeric, dimeric, and polymeric IgA with spec-Materials
ificity for DNP [2]. Previous studies have demonstratedPhosphate-buffered saline (PBS; 10 mmol/L sodium
that monomeric IgA does not efficiently activate comple-phosphate, pH 7.4, 0.15 mol/L NaCl) (NH4)2SO4, H2O2,
ment, while polymeric IgA activates the alternative path-oxalic acid (Merck, Darmstadt, Germany), Tween-20 (J.T.
way of complement both in vitro [21] and in vivo [20].Baker Chemicals Co., Deventer, The Netherlands), 2,29-
Polymeric IgA anti-DNP was purified from ascitic fluidamino-bis-3-ethylbenzthiazoline-6-sulfonic acid (ABTS),
by gel filtration column chromatography, as previouslybovine serum albumin (BSA), merthiolate (Sigma Chemi-
reported [2] without affinity purification. Purified IgAcal Company, St. Louis, MO, USA), fetal calf serum (FCS;
mAb (11.7 mg/mL) was aliquoted and stored at 2708CGIBCO BRL, Grand Island, NY, USA), and dipsticks
(Hema Combisticks; Bayer Diagnostics, Mijdrecht, The until use. Similarly, monomeric rat IgG2a anti-DNP (cell
Netherlands) were obtained as indicated. FITC-conju- line LO-DNP-41) was purified from ascitic fluid.
gated goat antimouse IgG was purchased from Nordic
Preparation of F(ab9)2 anti–Thy-1.1 antibodies and(Tilburg, The Netherlands). Mouse monoclonal antibod-
DNP conjugationies (mAb) antirat IgA heavy chain and mouse mAb
antirat IgG2a were obtained from Leuven University The generation and purification of a mouse mAb
(Leuven, Belgium). FITC-conjugated mouse mAb direc- IgG2a anti–Thy-1.1 has been reported before [22]. Pro-
ted against monocytes/macrophages (ED1) were kindly teins were dialyzed overnight against 0.2 mol/L sodium
provided by Dr. C.D. Dijkstra (Free University of Am- acetate, pH 4.2, at 48C. Sufficient pepsin was then added
sterdam, Amsterdam, The Netherlands) [19]. FITC or to give an enzyme:globulin weight ratio of 1:100. The
horseradish peroxidase (HRP)-conjugated rabbit antirat mixture was incubated at 378C for 20 hours. After neu-
C3 antibodies were generated in our own laboratory. tralization, the digest was clarified by centrifugation and
Mouse mAb recognizing the proliferating cell nuclear
fractionated on a HiLoad 26/60 Superdex 200 prepgrade
antigen (PCNA) in the late G1, S, G2, and M phases of
column. Fractions containing F(ab9)2 were pooled, con-the cell cycle [20] were obtained from Sigma Chemical
centrated, and subjected to DNP conjugation. DNP-Company. Mouse mAb directed against rat C6 and
F(ab9)2 was prepared by reaction of 60 mg of Na-2,4-mouse mAb directed against rat C5b-9 were kindly pro-
DNP-sulfonate with 30 mg F(ab9)2 for six hours at roomvided by Dr. W.G. Couser (Division of Nephrology, Uni-
temperature at a pH of 9.5. After gel filtration to removeversity of Washington, Medical Center, Seattle, WA,
free DNP, the number of DNP-lysine groups per F(ab9)2USA). These mAbs were coupled to digoxygenin (DIG)
was assessed by measuring the optical density at 360 nmaccording to the manufacturer’s instructions using DIG-
in 0.1 mol/L NaOH using the molar extinction coefficientNHS (Boehringer Mannheim, Mannheim, Germany).
of 17.530 for DNP-lysine. The purified DNP-F(ab9)2 anti-Also from Boehringer were the HRP-conjugated sheep
bodies had an average ratio of 2.8 DNP molecules perF(ab9) anti-DIG fragments and the mouse mAb antirat
F(ab9)2 molecule. They were designated as DNP-F(ab9)2,C3 antibodies. Tyramide FITC was purchased from NEN-
Dupont Research Products (Boston, MA, USA). DNP aliquoted, and stored at 2708C.
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In vivo experiments anesthesia. The glomeruli from each group were isolated
from pooled cortices as described earlier [23], and boundRat IgG anti-DNP antibody induced a dose-depen-
antibodies were eluted from glomeruli by incubation fordent proteinuria in rats (1.3 6 1.0, 2.5 6 1.5, 20.3 6 12.1,
one hour at room temperature in citric buffer, pH 2.5.78.1 6 10.2 mg/24 hours when 0, 0.025, 0.050, or 0.100 mg
The supernatant was neutralized using 1.0 N NaOH, andof IgG was administered, respectively). For this study, we
the amount of rat IgA and rat IgG that bound to theselected the dose of rat IgG that resulted in a maximal
kidneys was determined using isotype-specific enzyme-proteinuria of 20.3 6 12.1 mg protein/24 h on day 2,
linked immunosorbent assays (ELISAs), as described innondetectable C3 staining and an influx of 2.4 6 1.0
the next section of this article.macrophages in the glomerular area. Polymeric IgA anti-
DNP antibodies also induced a dose-dependent protein- ELISA
uria in rats. To study the aggravating effect of IgG on
Rat IgA or rat IgG was quantitated by coating a 96-the established IgA-induced glomerular inflammation,
well ELISA plate (Greiner) with affinity-purified rabbitwe selected the dose of rat IgA resulting in proteinuria
IgG antirat IgA or rabbit IgG antirat IgG antibodiesof 61 6 24.5 mg and 5.5 6 1.2 protein/24 hours on days
(both produced in our own laboratory; 1 mg/well) for2 and 7, respectively, moderate C3 staining, and an influx
two hours at 378C. Following a wash with PBS containingof 5.3 6 1.2 macrophages in the glomerular area. Protein-
0.05% Tween-20 (PBS-Tween), serial dilutions of kidneyuria rapidly decreased to nearly normal levels on day 7,
elutes diluted in PBS-Tween containing 0.5% fetal calfreflecting the temporary and subnephritogenic nature of
serum (PBS-Tween-FCS; starting at 1:10) were added tothe administered dose.
the wells in duplicate. Purified rat IgA and purified ratIn the present study, 24 young inbred male Wistar
IgG2a served as protein standards. The plates were incu-rats, weighing approximately 150 g, were divided into
bated for one hour at 378C. Because in rats almost 98%four groups of six rats each. All rats were administered
of the immunoglobulins contain the k light chain, bound400 mg of DNP2.8-F(ab9)2 anti–Thy-1.1 in PBS intrave- antibodies were detected by subsequent incubation fornously. After three hours, when DNP2.8-F(ab9)2 was no one hour at 378C with biotin-labeled monoclonal mouse
longer detectable in the circulation of rats, one group of
anti-rat k light chain (dilution 1:1000 in PBS-Tween-
rats received an intra-arterial (renal) injection of 5 mg FCS). After three washes, the wells were treated with
polymeric IgA in saline alone on day 0. The second peroxidase-labeled streptavidin and after 30 minutes
group received 0.050 mg of IgG alone, and the third filled with 100 mL of HRP substrate solution, ABTS.
group received an intra-arterial injection of 5 mg of poly- Adding 2% oxalic acid to each well after 30 minutes
meric IgA together with 0.050 mg of IgG in saline on the stopped the coloring reaction. Optical densities were
same day. The control group received an intra-arterial measured at 415 nm using a Titertek Multiskan plate
injection of the same volume of PBS alone. Blood and reader, and results are expressed accordingly.
24-hour urine samples were obtained before and on days Similarly, bound rat C3 was detected on rat IgA and/or
1, 2, 4, 7, 12, and 15 following antibody administration. IgG anti-DNP antibodies as follows: A 96-well ELISA
In addition, kidney biopsies were taken from all rats plate (Greiner) was coated with BTG-DNP114 (1 mg/well).
under halothane anesthesia before the start of the experi- After washing, wells were incubated with a dose response
ment, on days 1, 4, 7, and 15, after which all rats were of polymeric IgA antibodies diluted in PBS-Tween-FCS
sacrificed. Kidney biopsies were split in two. One half or diluted in rat IgG2a anti-DNP antibodies (1 mg/mL
was used for immunofluorescence (IF), and the other solution). After washing, wells were subsequently incu-
half was processed for light microscopy. bated with fresh normal rat serum (1:5 diluted in GVB 11/
MgEGTA) for one hour at 378C. Bound C3 was detected
Preparation of nephritic elutes using biotin-conjugated mouse mAb anti-rat C3 antibod-
For the quantitation of kidney-fixing antibodies, nine ies (1:800) followed by streptavidine-HRP (1:2000).
Wistar rats were divided into three groups of three rats
Histology and immunofluorescenceeach. All rats were injected with 400 mg of DNP-2.8 F(ab9)2
anti–Thy-1.1 on time point 0, and three hours later, one Renal tissue specimens (4 mm2) were fixed in methyl
group received an intra-arterial injection of 0.050 mg of Carnoy’s solution [24] and were paraffin embedded, sec-
monomeric rat IgG anti-DNP alone, the second group tioned, and stained with periodic acid-Schiff (PAS), hema-
received an intra-arterial injection of 5 mg of polymeric toxylin and eosin (HE), or methanamine silver. In each
rat IgA anti-DNP alone, and the third group received kidney specimen, at least 10 glomeruli were selected by
an intra-arterial injection of 0.050 mg of monomeric rat a predetermined mechanical walk [25] and evaluated by
IgG together with 5 mg of polymeric rat IgA anti-DNP. light microscopy for the presence of glomerular aneu-
After one hour, the kidneys of all rats were perfused rysms. Furthermore, using a superimposed grid on se-
lected glomeruli, the percentage of extracellular matrixwith 100 mL PBS by aortic puncture under halothane
van Dixhoorn et al: IgA- and IgG-mediated glomerulopathy 93
(ECM) per glomerular cross section was quantitated and performed using isotype-specific ELISAs (Fig. 2). Similar
amounts of anti-DNP antibodies bound to kidneys in allsubsequently subjected to statistical analysis, as described
later in this article. The number of proliferating glomeru- groups of rats analyzed. While the polymeric rat IgA- and
combination-receiving rats showed a moderate mesangiallar cells (PCNA positive) were counted in at least 10
glomeruli per renal cross section, and were averaged and deposition for rat C3, the rat IgG- and the PBS-treated
rats were essentially negative (Fig. 3). No glomerular stain-subjected to statistical analysis.
Kidney specimens were processed for IF according to ing for rat C6 was found in biopsies of rats injected with
PBS, limiting rat IgG or rat IgA alone in contrast tostandard procedures as described previously [22]. For the
detection of rat IgA or rat IgG2a, FITC-conjugated mouse enhanced glomerular deposition of rat C6 and rat C5b-9
in the combination group (Fig. 4).mAb antirat IgA or antirat IgG2a were used, respectively.
Photographs were taken on Kodak TX-400 film on a Leitz The glomerular influx of monocytes was quantitated on
day 1 (Fig. 5) and revealed that an additive, rather thanmicroscope equipped with a 4 mm BG 38 1 5 mm BG
12 filter for FITC. synergistic, increase in the average number of ED1-posi-
tive cells was observed in the combination group: 7.7 6
Proteinuria and hematuria 0.8 vs. 5.3 6 1.2 (IgA), 1.3 6 0.2 (PBS), or 2.4 6 1.0 (IgG).
For the assessment of proteinuria, the rats were housed
Proteinuria and hematuriain metabolic cages, and protein excretion was determined
in 24-hour urine samples containing 0.1% merthiolate by Before the start of the experiment, all rats had compa-
rable normal levels of urinary protein (ranging from 0Biuret method [2]. Hematuria was determined both by
dipsticks and direct microscopic enumeration of erythro- to 0.5 mg/24 hours). The administration of the limiting
dose of rat IgG resulted in proteinuria of 20.3 6 12.1cytes in full urine. Erythrocytes in three random 3400
microscopic fields from each of three separate urine sam- mg protein/24 hours on day 2 and 2.1 6 4.9 mg/24 hours
one week after injection (Fig. 6). A significant protein-ples were counted.
uria was observed in rats injected exclusively with rat
Statistical analysis IgA as compared with PBS or IgG-injected rats (P ,
0.05) on day 2, but proteinuria did not differ significantlyAll values are expressed as mean 6 SD unless stated
otherwise. Statistical analysis was performed using an un- from rats injected solely with rat IgG one week after the
injection. However, in the combination group, a signifi-paired Student’s t-test. In case of N 5 3, an independent
Student’s t-test was used. A P value smaller than 0.05 was cant (P , 0.05), increased proteinuria was observed on
day 7 as compared with the other groups of rats. Noconsidered significant.
significantly different proteinuric levels were measured
15 days after injection of antibodies in all groups (3.1 6
RESULTS
1.4, 4.1 6 2.0, and 3.8 6 2.3 for IgG, IgA, and IgG 1
Immunofluorescence IgA, respectively). Erythrocyturia was assessed using
dipsticks. On day 1, both rat IgA- and IgG-treated ratsThe constitutive expression of the Thy-1.1 epitope on
rat MCs enabled us to anchor DNP in the glomerular exhibited comparable hematuria [,50 and 20 red blood
cells (RBC)/mL full urine]. No significant difference wasmesangial area using DNP2.8-F(ab9)2 anti-Thy-1.1 antibod-
ies. We previously demonstrated that injection of this found with the groups of rats receiving the combination
of rat isotypes on days 1 and 7 (data not shown). Onanchor to rats results in a uniform glomerular staining for
mouse Ig, but does not elicit glomerular inflammation nor day 15, none of the rats revealed hematuria exceeding
background levels (0, trace amounts).autologous antibody production [2].
All rats injected with the anchor showed a uniform
Light microscopyglomerular staining for mouse IgG. Furthermore, the min-
imal dose of rat IgG resulted in a weak positive mesangial Light microscopy for histologic abnormalities of biop-
sies of rats injected with rat IgG revealed focal MC lysis,staining of rat IgG upon injection (data not shown). Infu-
sion of polymeric rat IgA to rats resulted in mesangial diffuse and moderate MC proliferation, and slight ECM
expansion on day 7 after injection (Fig. 7). Similarly, thedeposition of IgA antibodies on day 1 (Fig. 1). In addition,
the combination of IgG together with IgA resulted in animals that received rat IgA alone exhibited moderate
MC proliferation with no gross histologic abnormalitiescomparable intensities of deposition of these antibodies
as compared with single antibody injections. On day 7, a on day 7. Figure 7 shows the histology of kidney biopsies
seven days after disease induction. Aneurysm formationreduced staining for both IgG and IgA was observed (data
not shown). was clearly visible only when both IgA and IgG were
administered, generally revealing the severity and fierce-To demonstrate that equal amounts of antibody iso-
types deposit in the single versus combined situation, ness of this model (Fig. 7D). A significantly increased
percentage of glomeruli was affected by aneurysm for-quantitation of acid-eluted kidney-bound antibodies was
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Fig. 1. Immunofluorescent staining for rat
IgA in glomeruli of rats injected with PBS
(A), rat IgG (B), or a subnephritogenic dose
of rat IgA (C ) or the combination of rat IgG
together with polymeric rat IgA (D) on day
1 after injection (all, 3250).
34.2 6 1.9% for PBS, IgG, and IgA rats, respectively).
Finally, enhanced MC proliferation was observed in
biopsies of rats receiving the combination on day 15 (5.4 6
3.9 vs. 0.6 6 0.7, 1.8 6 1.1, and 2.3 6 1.9 for PBS, IgG,
and IgA treated rats, respectively).
ELISA
Thus far, we have observed that a combined deposition
of IgA and IgG in the glomerular mesangial area aug-
ments renal inflammation. To determine whether com-
plement activation was directly involved, increasingFig. 2. Quantitation of kidney-bound monoclonal rat antibodies one
amounts of polymeric IgA with or without fixed amountshour after injection. No significant difference in the amount of bound
antibodies could be detected between groups of rats injected with single of rat IgG were exposed to rat C3 in vitro. A synergisti-
or combined antibodies. Depicted are averages of N 5 3 6 SD. Symbols
cally enhanced C3 fixation was observed with the combi-are: (h) polymeric rat IgA; (j) rat IgG.
nation of anti-DNP antibodies, in contrast to incubation
of rat C3 with either antibody alone (Fig. 9).
mation on day 7 only in this group (10.5 6 8.52%; Fig. 8).
DISCUSSIONECM expansion was not higher in the combination group
on day 7 (38.4 6 3.6% vs. 26.4 6 5.3%, 43.5 6 4.4%, This study was performed to investigate the inflamma-
tory potential of codeposition of polymeric rat IgA to-and 44.0 6 5.1% for PBS, IgG, and IgA treated rats,
respectively). However, increased mesangial ECM was gether with rat IgG in rat kidneys. Using subnephrito-
genic doses of polymeric IgA and minimal amounts ofobserved on day 15 after injection in the combination
group (45.2 6 2.3% vs. 27.2 6 3.1%, 33.3 6 4.4%, and IgG, we established two limiting pathogenic conditions
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Fig. 3. Immunofluorescent staining using a
rabbit polyclonal antibody directed against rat
C3 on kidney cross-sections of rats injected
with PBS (A), IgG (B), polymeric IgA (C ),
or a combination of IgG in the presence of
polymeric IgA (D) on day 1 after the injection
(all, 3250). Rat C3 was only detected in glo-
meruli of rats treated with polymeric rat IgA
alone or the combination of antibodies.
from which various disease characteristics could easily ing the alternative pathway convertase C3bBb. The alter-
native pathway C3 convertase subsequently cleaves C3develop when used in combination. For both polymeric
rat IgA and IgG, respectively, we chose complement and generates more C3 cleavage products. We therefore
hypothesize that participation of the classic pathway inactivation, hematuria, proteinuria, MC proliferation, and
ECM expansion as disease parameters. This was done IgA-mediated glomerulopathy may induce a prolonged
and more severe type of GN.to be able to draw a parallel with the disease characteris-
tics of patients with IgAN. We observed that, as expected, The capacity of polymeric IgA to ignite in situ renal
inflammation has been demonstrated [reviewed in 27].with an increasing dose of IgG, more complement was
deposited in glomeruli of rats, and simultaneously, rats Hematuria was observed when complement-fixing IgG
was cointroduced together with IgA [16, 17], suggestingwere more proteinuric with more glomerular inflamma-
tory cells and increased glomerular sclerosis. However, that in these models, IgA alone is not sufficient to result
in glomerular scarring and renal deterioration. In ourthe question in this study does not reside in the inflam-
matory capacity of IgG. We focused on the inflammatory model, polymeric IgA alone is able to dose-dependently
induce the full-blown disease characteristics resemblingpotential of polymeric rat IgA in the presence of limiting,
noninjurious IgG. those of patients with IgAN [2]. However, our model is
acute and based on a single infusion of IgA antibodiesApparently, in rats treated with the combination of
rat IgA and IgG, complement can be more effectively and does not infer irreversibility of glomerulopathy. Re-
petitive injections of minimal IgA with or without IgGactivated. Activation of rat complement by rat or mouse
IgG2a antibodies proceeds through the classic pathway, could better reflect the actual situation in IgAN and may
ultimately result in an irreversible glomerular inflamma-as demonstrated by C1 binding [26]. IgG2a forms the
classic pathway convertase C4bC2a through C1 fixation, tion in rats.
Moreover, in this acute model, we observed glomeru-and subsequently cleaves C3 into C3a and C3b. A greater
number of complement-activating moieties in the mesan- lar aneurysms, a feature not frequently observed in IgAN
[28]. The complement-activating antibody depositionsgial area result in more C3 convertase formation, includ-
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Fig. 4. Immunofluorescent staining using a
mouse monoclonal antibody directed against
rat C5b-9 on kidney cross-sections of rats in-
jected with PBS (A), rat IgG (B), polymeric
rat IgA (C ), or a combination of minimal rat
IgG in the presence of polymeric IgA (D) on
day 1 after the injection (all, 3250). Rat C5b-9
was exclusively detected in the glomeruli of
rats treated with the combination of anti-
bodies.
Fig. 5. Depiction of the average number of monocytes and macro-
phages per glomerular cross-section on day 1 after antibody administra-
tion. An additive increase in the average number of ED11 cells was
detected on day 1 in the groups of rats receiving both rat IgA and IgG
as compared with groups of rats that received an exclusive injection of
PBS, polymeric rat IgA, or rat IgG. Shown are averages of N 5 6 6
SD per group. Fig. 6. Assessment of proteinuria two and seven days after antibody
injection. A significant (P , 0.05), increased proteinuria was found in
the combination group (A) as compared with groups of rats injected
with PBS (B), single IgG (C ), or IgA (D) antibodies on day 7. Depicted
are averages of N 5 6 6 SD per group.and the sudden inflammatory impact on the mesangium
most likely caused the glomerular aneurysm formations
seen in our study. Aneurysmatic lesions in IgG antibody-
its of C6 and C5b-9, supporting the notion that comple-induced anti–Thy-1.1 glomerulonephritis were decreased
ment activation and glomerular aneurysms are two relatedwhen rats were depleted of complement prior to disease
entities in immunoglobulin-induced GN. The ELISA un-induction [29]. Indeed, rats receiving the combination of
anti-DNP antibodies revealed strong glomerular depos- derscores the involvement of complement in our study;
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Fig. 7. Light microscopy of rat kidney cross-
sections seven days after administration of
PBS (A), rat IgG alone (B), polymeric rat IgA
alone (C), or the combination of IgG together
with polymeric IgA (D; PAM staining, 3250).
Aneurysm formation is clearly visible in the
glomerulus of a rat that received the combina-
tion of antibodies.
that is, polymeric IgA and monomeric IgG cooperate,
and the aggravating effect of IgG on the polymeric IgA-
induced glomerular scarring is complement dependent.
The systemic effect of large-sized IgA has been studied
extensively in our department [30, 31]. In general, in
the presence of complement, aggregated IgA is rapidly
cleared through the liver involving a central role for
Kupffer cells. No decrease of plasma complement levels
was detected when dimeric or polymeric IgA was admin-
istered to rats, suggesting that excessive fluid phase acti-
vation of complement does not occur.
We used the constitutively expressed Thy-1.1 epitope
on the surface of rat MCs as an in vivo anchor to quantita-
tively deposit rat immunoglobulins in the mesangial area
in a reproducible, antigen-dependent manner. Coinfu-
sion of polymeric rat IgA together with monomeric IgG
resulted in similar immune deposit formation as com-
pared with single antibody administrations. This suggests
that the combined injection of antibodies does not affect
glomerular deposition of neither IgA nor IgG. Further- Fig. 8. Average percentage (6 SEM) of aneurysm formation in kidney
more, injection to rats of 7.5 mg polymeric IgA does biopsies of rats injected with PBS, rat IgG, polymeric rat IgA, or the
combination of antibodies on day 7. The group of rats receiving thenot exceed the proteinuric effects observed when the
combination of antibodies revealed a significant (P , 0.05) increasedcombination of 5 mg polymeric IgA and 0.05 mg IgG percentage of aneurysms as compared with rats receiving PBS or single
antibody injections alone. Depicted are averages (N 5 6) 6 SD.are simultaneously injected (46.1 6 42.8 mg/24 h). The
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thy, we provide evidence that glomerular codeposition
of IgA together with IgG aggravates renal injury in a
complement-dependent fashion.
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